← FDA Drug Approvals (Drugs@FDA)

CEFTRIAXONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2006-02-15

Drug application

FDA Application #

ANDA065245

Application type

Abbreviated New Drug Application (Generic)

Brand name

CEFTRIAXONE

Generic name

Ceftriaxone Sodium

Active ingredients

CEFTRIAXONE SODIUM

Dosage form

INJECTABLE

Route

INTRAMUSCULAR, INTRAVENOUS

Marketing status

Discontinued

Sponsor

FRESENIUS KABI USA

First approval

2006-02-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown